Publication Information

{'id': 'https://openalex.org/W3148586516', 'doi': 'https://doi.org/10.1080/00325481.1971.11697601', 'title': 'Drug-Induced Movement Disorders', 'display_name': 'Drug-Induced Movement Disorders', 'publication_year': 1971, 'publication_date': '1971-09-01', 'ids': {'openalex': 'https://openalex.org/W3148586516', 'doi': 'https://doi.org/10.1080/00325481.1971.11697601', 'mag': '3148586516', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/5092993'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1080/00325481.1971.11697601', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S11800902', 'display_name': 'Postgraduate Medicine', 'issn_l': '0032-5481', 'issn': ['0032-5481', '1941-9260'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5062584958', 'display_name': 'Richard R. North', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I867280407', 'display_name': 'The University of Texas Southwestern Medical Center', 'ror': 'https://ror.org/05byvp690', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I867280407']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Richard R. North', 'raw_affiliation_strings': ['The University of Texas (Southwestern) Medical School at Dallas'], 'affiliations': [{'raw_affiliation_string': 'The University of Texas (Southwestern) Medical School at Dallas', 'institution_ids': ['https://openalex.org/I867280407']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5062584958'], 'corresponding_institution_ids': ['https://openalex.org/I867280407'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.799, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 5, 'citation_normalized_percentile': {'value': 0.738462, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 76, 'max': 78}, 'biblio': {'volume': '50', 'issue': '3', 'first_page': '180', 'last_page': '185'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10094', 'display_name': 'Epilepsy research and treatment', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10094', 'display_name': 'Epilepsy research and treatment', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12229', 'display_name': 'Pharmacological Effects and Toxicity Studies', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T13230', 'display_name': 'Synthesis and Reactivity of Heterocycles', 'score': 0.9959, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/movement-disorders', 'display_name': 'Movement Disorders', 'score': 0.6824049}], 'concepts': [{'id': 'https://openalex.org/C2780304432', 'wikidata': 'https://www.wikidata.org/wiki/Q300989', 'display_name': 'Levodopa', 'level': 4, 'score': 0.9527595}, {'id': 'https://openalex.org/C2776525014', 'wikidata': 'https://www.wikidata.org/wiki/Q1531991', 'display_name': 'Parkinsonism', 'level': 3, 'score': 0.93965816}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9052278}, {'id': 'https://openalex.org/C2778261627', 'wikidata': 'https://www.wikidata.org/wiki/Q2608695', 'display_name': 'Movement disorders', 'level': 3, 'score': 0.6824049}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.62614626}, {'id': 'https://openalex.org/C2779734285', 'wikidata': 'https://www.wikidata.org/wiki/Q11085', 'display_name': "Parkinson's disease", 'level': 3, 'score': 0.30949205}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.27190277}, {'id': 'https://openalex.org/C118552586', 'wikidata': 'https://www.wikidata.org/wiki/Q7867', 'display_name': 'Psychiatry', 'level': 1, 'score': 0.2424371}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.1930215}], 'mesh': [{'descriptor_ui': 'D004295', 'descriptor_name': 'Dihydroxyphenylalanine', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D009069', 'descriptor_name': 'Movement Disorders', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': True}, {'descriptor_ui': 'D010300', 'descriptor_name': 'Parkinson Disease', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D014149', 'descriptor_name': 'Tranquilizing Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D000661', 'descriptor_name': 'Amphetamine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000661', 'descriptor_name': 'Amphetamine', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D003276', 'descriptor_name': 'Contraceptives, Oral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003276', 'descriptor_name': 'Contraceptives, Oral', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D004295', 'descriptor_name': 'Dihydroxyphenylalanine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004422', 'descriptor_name': 'Dystonia Musculorum Deformans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004422', 'descriptor_name': 'Dystonia Musculorum Deformans', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009069', 'descriptor_name': 'Movement Disorders', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010300', 'descriptor_name': 'Parkinson Disease', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010640', 'descriptor_name': 'Phenothiazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010640', 'descriptor_name': 'Phenothiazines', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D012110', 'descriptor_name': 'Reserpine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012110', 'descriptor_name': 'Reserpine', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D014149', 'descriptor_name': 'Tranquilizing Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1080/00325481.1971.11697601', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S11800902', 'display_name': 'Postgraduate Medicine', 'issn_l': '0032-5481', 'issn': ['0032-5481', '1941-9260'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/5092993', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.83, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 14, 'referenced_works': ['https://openalex.org/W1988460412', 'https://openalex.org/W2010571640', 'https://openalex.org/W2021583460', 'https://openalex.org/W2043322034', 'https://openalex.org/W2069837065', 'https://openalex.org/W2083987381', 'https://openalex.org/W2086202657', 'https://openalex.org/W2115674974', 'https://openalex.org/W2272293723', 'https://openalex.org/W2337142316', 'https://openalex.org/W2401546345', 'https://openalex.org/W2404897037', 'https://openalex.org/W2415920319', 'https://openalex.org/W4239243471'], 'related_works': ['https://openalex.org/W3148586516', 'https://openalex.org/W2419345374', 'https://openalex.org/W2315774369', 'https://openalex.org/W2175236109', 'https://openalex.org/W2124414252', 'https://openalex.org/W2123722343', 'https://openalex.org/W2012174707', 'https://openalex.org/W1980588181', 'https://openalex.org/W1976145727', 'https://openalex.org/W1975681203'], 'abstract_inverted_index': {'In': [0, 11], 'general,': [1], 'phenothiazines': [2, 30], 'and': [3, 35], 'levodopa': [4, 41], 'have': [5, 72], 'appeared': [6], 'to': [7, 51, 78], 'exert': [8], 'opposite': [9], 'effects.': [10], 'view': [12], 'of': [13, 21, 43, 58, 64, 68], 'this,': [14], 'the': [15, 36, 56, 65, 69], 'similarities': [16], 'between': [17], 'a': [18, 32], 'late': [19], 'syndrome': [20], 'abnormal': [22, 37], 'movements': [23, 38], 'seen': [24], 'in': [25, 53], 'some': [26], 'patients': [27], 'treated': [28], 'with': [29, 40], 'over': [31], 'long': [33], 'period': [34], 'associated': [39], 'therapy': [42], 'parkinsonism': [44], 'are': [45], 'puzzling.': [46], 'The': [47], 'levodopa-induced': [48], 'disorders': [49, 71], 'respond': [50], 'reduction': [52], 'dosage,': [54], 'but': [55], 'cost': [57], 'this': [59], 'improvement': [60], 'may': [61], 'be': [62], 'worsening': [63], 'parkinsonism.': [66], 'Some': [67], 'neuroleptic-induced': [70], 'been': [73], 'slowly': [74], 'reversible': [75], 'or': [76], 'unresponsive': [77], 'treatment.': [79]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3148586516', 'counts_by_year': [{'year': 2013, 'cited_by_count': 1}], 'updated_date': '2024-12-10T08:26:35.927830', 'created_date': '2021-04-13'}